Schulhoff & Co’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.22M | Hold |
137,500
| – | – | 0.54% | 45 |
|
2025
Q1 | $1.08M | Buy |
137,500
+500
| +0.4% | +$3.92K | 0.48% | 51 |
|
2024
Q4 | $1.44M | Hold |
137,000
| – | – | 0.53% | 41 |
|
2024
Q3 | $1.8M | Hold |
137,000
| – | – | 0.75% | 35 |
|
2024
Q2 | $1.93M | Hold |
137,000
| – | – | 0.87% | 27 |
|
2024
Q1 | $2.31M | Buy |
137,000
+41,000
| +43% | +$692K | 1.01% | 25 |
|
2023
Q4 | $1.36M | Hold |
96,000
| – | – | 0.65% | 43 |
|
2023
Q3 | $989K | Hold |
96,000
| – | – | 0.5% | 50 |
|
2023
Q2 | $1.58M | Hold |
96,000
| – | – | 0.74% | 39 |
|
2023
Q1 | $879K | Hold |
96,000
| – | – | 0.41% | 56 |
|
2022
Q4 | $687K | Hold |
96,000
| – | – | 0.32% | 62 |
|
2022
Q3 | $480K | Hold |
96,000
| – | – | 0.25% | 70 |
|
2022
Q2 | $234K | Buy |
96,000
+35,000
| +57% | +$85.3K | 0.11% | 101 |
|
2022
Q1 | $416K | Hold |
61,000
| – | – | 0.18% | 78 |
|
2021
Q4 | $492K | Hold |
61,000
| – | – | 0.2% | 73 |
|
2021
Q3 | $597K | Hold |
61,000
| – | – | 0.27% | 68 |
|
2021
Q2 | $410K | Hold |
61,000
| – | – | 0.18% | 80 |
|
2021
Q1 | $551K | Hold |
61,000
| – | – | 0.25% | 69 |
|
2020
Q4 | $407K | Hold |
61,000
| – | – | 0.2% | 76 |
|
2020
Q3 | $307K | Buy |
+61,000
| New | +$307K | 0.17% | 80 |
|